Patents by Inventor Steve Bobzin

Steve Bobzin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240049666
    Abstract: The present invention relates to methods of breeding in Cannabis plants having a Value Phenotype.
    Type: Application
    Filed: January 28, 2022
    Publication date: February 15, 2024
    Inventors: DANIEL BARRERA, ADAM CRISWELL, JON MYRVOLD, STEVE BOBZIN, JOHN DE FRIEL
  • Publication number: 20220256798
    Abstract: The present invention relates to day-length neutral Cannabis plants with one or more value phenotypes.
    Type: Application
    Filed: February 16, 2022
    Publication date: August 18, 2022
    Inventors: Adam Criswell, Daniel Barrera, Steve Bobzin, John De Friel
  • Patent number: 6750247
    Abstract: Compounds that are effective lipoxygenase inhibitors, and methods and pharmaceutical compositions for inhibiting lipoxygenases and for treatment of lipoxygenase-mediated conditions in humans and other subjects. The compounds, methods and pharmaceutical compositions utilize subersic terpenoids, jaspic terpenoids, igernellic terpenoids, hippospongic terpenoids, halicondric terpenoids, dictyodendric terpenoids, and/or heteronemic terpenoids, and synthetic derivatives or analogs thereof. Exemplary compounds include (−)-subersic acid, (+)-subersin, jaspaquinol, (−)-jaspic acid, igernellin, halisufate 7, and hipposulfate C and D, and derivatives thereof.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: June 15, 2004
    Assignee: Galileo Laboratories, Inc.
    Inventors: Phillip Crews, Jennifer Carroll, Theodore Holman, Guy Miller, Steve Bobzin, Lesley Brown
  • Publication number: 20030065025
    Abstract: Compounds that are effective lipoxygenase inhibitors, and methods and pharmaceutical compositions for inhibiting lipoxygenases and for treatment of lipoxygenase-mediated conditions in humans and other subjects. The compounds, methods and pharmaceutical compositions utilize subersic terpenoids, jaspic terpenoids, igernellic terpenoids, hippospongic terpenoids, halicondric terpenoids, dictyodendric terpenoids, and/or heteronemic terpenoids, and synthetic derivatives or analogs thereof. Exemplary compounds include (−)-subersic acid, (+)-subersin, jaspaquinol, (−)-jaspic acid, igernellin, halisufate 7, and hipposulfate C and D, and derivatives thereof.
    Type: Application
    Filed: May 31, 2002
    Publication date: April 3, 2003
    Inventors: Phillip Crews, Jennifer Carroll, Theodore Holman, Guy Miller, Steve Bobzin, Lesley Brown